Ayala Pharmaceuticals Inc (ADXS)

[shub]

Mastiffs;
"Not waiting another year"...Hah!

Do you see any massive, double blind , phase 3 clinical studies
testing our lead AXAL construct against a general cervical cancer population?

That's the one we have the best data and most solid clinical proof on and our best chance at FDA marketing approval. Right?

That would take another 3+ years, at least...Plus the FDA delays...plus...

And we haven't even started....And should have years ago when a ph 3 only cost $100.000 or so. We had the money then.